Sagimet Biosciences (SGMT) Change in Accured Expenses: 2023-2024
Historic Change in Accured Expenses for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to -$1.7 million.
- Sagimet Biosciences' Change in Accured Expenses fell 219.51% to -$1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$1.0 million, marking a year-over-year change of. This contributed to the annual value of -$907,000 for FY2024, which is 855.83% down from last year.
- As of Q3 2024, Sagimet Biosciences' Change in Accured Expenses stood at -$1.7 million, which was down 252.15% from $1.1 million recorded in Q2 2024.
- Over the past 5 years, Sagimet Biosciences' Change in Accured Expenses peaked at $1.4 million during Q3 2023, and registered a low of -$1.7 million during Q3 2024.
- Its 2-year average for Change in Accured Expenses is -$175,857, with a median of -$396,000 in 2023.
- Over the last 5 years, Sagimet Biosciences' Change in Accured Expenses had its largest YoY gain of 375.51% in 2024, and its largest YoY loss of 219.51% in 2024.
- Sagimet Biosciences' Change in Accured Expenses (Quarterly) stood at $320,000 in 2023, then crashed by 219.51% to -$1.7 million in 2024.
- Its Change in Accured Expenses was -$1.7 million in Q3 2024, compared to $1.1 million in Q2 2024 and -$782,000 in Q1 2024.